Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales (PACUTI)

NCT05224401 is registered in ClinicalTrials.gov with Lund University as lead sponsor.

NCT NCT05224401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales (PACUTI)
Lead sponsor
Lund University
Phase
Phase 3
Overall status
Recruiting
Start date
May 29, 2023
Completion date
September 1, 2027
Enrollment
330 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, bacteremia, urinary tract infections